Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-01-02 Sale | 2026-01-02 9:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 1,879 | $13.73 | $25,799 | 83,095 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 9:00 pm | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 2,505 | $13.73 | $34,394 | 265,725 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 9:00 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 8,072 | $13.73 | $110,829 | 719,682 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 9:00 pm | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 2,401 | $13.73 | $32,966 | 206,421 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 9:00 pm | Janux Therapeutics Inc. | JANX | McIver Zachariah Chief Medical Officer | 2,714 | $13.73 | $37,263 | 153,786 (Direct) | View |
| 2026-01-02 Sale | 2026-01-02 9:00 pm | Janux Therapeutics Inc. | JANX | Dobek Maria Vice President, Accounting | 1,462 | $13.73 | $20,073 | 76,908 (Direct) | View |
| 2025-12-01 Sale | 2025-12-03 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $32.98 | $109,929 | 199,742 (Direct) | View |
| 2025-11-14 Sale | 2025-11-14 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $30 | $99,990 | 203,075 (Direct) | View |
| 2025-10-28 Sale | 2025-10-30 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 16,665 | $30.06 | $500,987 | 280,906 (Direct) | View |
| 2025-05-01 Sale | 2025-05-02 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $32.03 | $106,745 | 169,471 (Direct) | View |
| 2025-04-21 Sale | 2025-04-23 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $30 | $100,020 | 172,804 (Direct) | View |
| 2025-03-05 Purchase | 2025-03-07 6:05 pm | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 824,041 | $30.75 | $25,342,965 | 11,189,693 (Indirect) | View |
| 2025-03-03 Sale | 2025-03-05 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $32.15 | $107,174 | 176,138 (Direct) | View |
| 2025-02-03 Sale | 2025-02-05 8:00 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $42.29 | $140,999 | 179,472 (Direct) | View |
| 2025-01-07 Sale | 2025-01-08 8:00 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 5,000 | $60 | $300,004 | 293,054 (Direct) | View |
| 2025-01-02 Sale | 2025-01-03 5:10 pm | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 13,334 | $54.88 | $731,785 | 145,139 (Direct) | View |
| 2024-12-24 Sale | 2024-12-27 8:00 pm | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 25,000 | $56.19 | $1,404,805 | 217,054 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-02-02 Option Award | 2026-02-04 8:01 pm | N/A 2036-02-01 | Janux Therapeutics Inc. | JANX | Go William Chief Medical Officer | 198,000 | $0 | 198,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-02 9:00 pm | N/A 2036-01-01 | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 141,300 | $0 | 265,725 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-02 9:00 pm | N/A 2036-01-01 | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 434,700 | $0 | 719,682 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-02 9:00 pm | N/A 2036-01-01 | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 128,700 | $0 | 206,421 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-02 9:00 pm | N/A 2036-01-01 | Janux Therapeutics Inc. | JANX | McIver Zachariah Chief Medical Officer | 130,500 | $0 | 153,786 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-02 9:00 pm | N/A 2036-01-01 | Janux Therapeutics Inc. | JANX | Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr | 162,000 | $0 | 206,000 (Direct) | View |
| 2026-01-02 Option Award | 2026-01-02 9:00 pm | N/A 2036-01-01 | Janux Therapeutics Inc. | JANX | Dobek Maria Vice President, Accounting | 61,535 | $0 | 76,908 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $10.59 | 199,742 (Direct) | View |
| 2025-12-01 Exercise | 2025-12-03 8:00 pm | N/A 2031-05-13 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $0 | 199,742 (Direct) | View |
| 2025-11-14 Exercise | 2025-11-14 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $10.59 | 203,075 (Direct) | View |
| 2025-11-14 Exercise | 2025-11-14 8:00 pm | N/A 2031-05-13 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $0 | 203,075 (Direct) | View |
| 2025-10-28 Exercise | 2025-10-30 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 6,666 | $10.59 | 280,906 (Direct) | View |
| 2025-10-28 Exercise | 2025-10-30 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 9,999 | $4.21 | 280,906 (Direct) | View |
| 2025-10-28 Exercise | 2025-10-30 8:00 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 16,665 | $0 | 280,906 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:33 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | RA CAPITAL MANAGEMENT L.P. RA Capital Healthcare Fund LP RA Capital Nexus Fund II L.P. Kolchinsky Peter Shah Rajeev M. Director 10% Owner | 15,417 | $0 | 11,207,610 (Indirect) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | Barrett Ronald W Director | 15,417 | $0 | 17,917 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | CAPPS VICKIE L Director | 15,417 | $0 | 85,765 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | DOBMEIER ERIC Director | 15,417 | $0 | 21,648 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | Gujrathi Sheila Director | 15,417 | $0 | 130,556 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | Hernday Natasha Director | 15,417 | $0 | 20,398 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | McNulty Alana B. Director | 15,417 | $0 | 17,917 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | Simson Jake Director | 15,417 | $0 | 17,917 (Direct) | View |
| 2025-06-11 Option Award | 2025-06-13 7:30 pm | N/A 2035-06-10 | Janux Therapeutics Inc. | JANX | Kung Winston Director | 15,417 | $0 | 17,917 (Direct) | View |
| 2025-06-02 Option Award | 2025-06-04 8:00 pm | N/A 2035-06-01 | Janux Therapeutics Inc. | JANX | Doyle Janeen Noel Chief Corp. & Bus. Dev. Ofcr | 198,000 | $0 | 198,000 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-02 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $4.21 | 169,471 (Direct) | View |
| 2025-05-01 Exercise | 2025-05-02 8:00 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,333 | $0 | 169,471 (Direct) | View |
| 2025-04-21 Exercise | 2025-04-23 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $4.21 | 172,804 (Direct) | View |
| 2025-04-21 Exercise | 2025-04-23 8:00 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $0 | 172,804 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $4.21 | 176,138 (Direct) | View |
| 2025-03-03 Exercise | 2025-03-05 8:00 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $0 | 176,138 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-05 8:00 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $4.21 | 179,472 (Direct) | View |
| 2025-02-03 Exercise | 2025-02-05 8:00 pm | N/A 2031-03-09 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 3,334 | $0 | 179,472 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 8:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | McIver Zachariah Chief Medical Officer | 117,000 | $0 | 117,000 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 8:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 103,500 | $0 | 157,788 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 8:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | Campbell David Alan President and CEO | 364,500 | $0 | 581,554 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 8:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | Robinson Byron Chief Strategy Officer | 126,000 | $0 | 126,000 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 8:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | DiRaimondo Thomas Chief Scientific Officer | 108,000 | $0 | 213,719 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 8:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | Dobek Maria Vice President, Accounting | 45,500 | $0 | 45,501 (Direct) | View |
Ownership(A) | 2025-01-03 8:01 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Winter Charles M. Chief Technical Officer | 0 | $0 | 46,111 (Direct) | View |
Ownership | 2025-01-03 8:00 pm | N/A 2033-05-31 | Janux Therapeutics Inc. | JANX | McIver Zachariah Chief Medical Officer | 0 | $0 | 146,200 (Direct) | View |
| 2025-01-02 Option Award | 2025-01-03 5:10 pm | N/A 2035-01-01 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 81,000 | $0 | 145,139 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 6:25 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 9,880 | $20.24 | 264,342 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 6:25 pm | N/A 2032-01-02 | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 9,881 | $0 | 264,342 (Direct) | View |
| 2024-12-19 Exercise | 2024-12-20 6:25 pm | N/A N/A | Janux Therapeutics Inc. | JANX | Meyer Andrew Hollman Chief Business Officer | 1 | $14.02 | 264,342 (Direct) | View |